
APYX — Apyx Medical Inc
NASDAQ · Healthcare · Medical Devices
$3.06
+$0.01 (+0.31%)
Apyx Medical Inc (APYX) is a medical devices company listed on NASDAQ. It is led by Charles D. Goodwin II, based in 5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004, with about 205 employees. Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Latest reported APYX revenue for 2025-09-30 was $12.9M. Net income was -$2.0M. Revenue was up 13.2% from 2025-06-30 to 2025-09-30. APYX currently screens at market cap $179.6M.
Use this APYX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the APYX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the APYX SEC filings page. Lician reads the product cache first so this HTML stays unique to Apyx Medical Inc even when a live quote feed is slow.
About Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
APYX Key Statistics
Market Cap
$179.64M
Volume
48,425
Previous Close
$3.08
Day Range
$3.09 – $3.24
EPS
$0.00
Revenue
$48.10M
Net Income
-$23.56M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-8.1%
Profit Margin
-49.0%
Employees
205
APYX Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $48.10M | $52.35M | $44.51M | $48.52M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$23.56M | -$18.85M | -$23.28M | -$15.20M |
| EPS (Diluted) | $0.00 | -$0.54 | -$0.67 | -$0.44 |
Total Assets
$64.84M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$31.74M
Operating Cash Flow
-$18.05M
Free Cash Flow
$0.00
Apyx Medical Inc Company Information
- President, CEO & Director
- Charles D. Goodwin II
- Headquarters
- 5115 Ulmerton Road, Clearwater, FL, United States, 33760-4004
- Website
- apyxmedical.com
- Phone
- 727 384 2323
- IPO / Founded
- 1987-01-01
- Sector
- Healthcare
- Industry
- Medical Devices